Pegylated liposomal doxorubicin-induced hand-foot syndrome predicted by serum metabolomic profiling and prevented by calcium dobesilate

J Am Acad Dermatol. 2022 Mar;86(3):688-690. doi: 10.1016/j.jaad.2021.02.079. Epub 2021 Mar 5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibiotics, Antineoplastic / adverse effects
  • Calcium Dobesilate*
  • Doxorubicin / adverse effects
  • Doxorubicin / analogs & derivatives
  • Hand-Foot Syndrome* / etiology
  • Humans
  • Polyethylene Glycols / adverse effects

Substances

  • Antibiotics, Antineoplastic
  • liposomal doxorubicin
  • Polyethylene Glycols
  • Calcium Dobesilate
  • Doxorubicin